Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$79.22 - $105.37 $79,220 - $105,370
1,000 Added 66.67%
2,500 $254,000
Q1 2023

May 12, 2023

BUY
$30.85 - $93.17 $46,275 - $139,755
1,500 New
1,500 $136,000
Q2 2019

Aug 14, 2019

SELL
$77.72 - $94.35 $466,320 - $566,100
-6,000 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$51.9 - $101.79 $311,400 - $610,740
6,000 New
6,000 $513,000

Others Institutions Holding RETA

About REATA PHARMACEUTICALS INC


  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.